Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression

NCT ID: NCT00818506

Last Updated: 2012-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

55 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies show that depression is a risk factor for the development of coronary artery disease (CAD). Furthermore there is an increased occurrence of depression in patients with CAD. Among other mechanisms atherosclerosis is believed to play a central role regarding these notable associations between depression and CAD. Moreover, patients with late onset major depression have an increased number of small lesions found in the white matter of the brain, the so-called white matter lesions. The main goal of this project is to examine if CAD is associated with depression and/or white matter lesions. CAD is evaluated using coronary CT angiography. Depression is evaluated using a semi-structured diagnostic interview. White matter lesions are quantified using cerebral magnetic resonance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Major Depressive Disorder Cardiovascular Disease Coronary Artery Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Depression Major depressive disorder Coronary artery disease White Matter Hyperintensities White Matter Lesions Coronary artery calcification

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Late onset MDD

Patients with major depressive disorder between 50 and 70 years of age that did not suffer from depression before the age of 50.

No interventions assigned to this group

Controls

Healthy controls (matched for age, sex, and tobacco use status)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Submitted to psychiatric hospital, district psychiatry or private psychiatrist because of major depressive disorder.
* Meets the criteria for Major Depressive Disorder, Single Episode as defined in the Diagnostic and Statistical Manual, fourth edition (DSM-IV) and the International Classification of Diseases (ICD-10).
* Age 50-70 years.
* Written informed consent.
* Caucasian.

Exclusion Criteria

* Known, or anamnestic/objective signs of, organic brain disease.
* Organic, including symptomatic, mental disorders as (ICD-10: F00-F09).
* Dependence syndrome within the last 5 years (ICD-10: F1x.2) or current harmful use (ICD-10: F1x.1) of alcohol or other psychoactive substances.
* Schizophrenia, schizotypal and delusional disorders (ICD-10: F20-F29).
* Subject to force of law according to the danish law on psychiatry.
* Present risk of suicide.
* Previous cranial trauma resulting in unconsciousness for more than 2 minutes.
* Medical history of renal failure.
* Other conditions which contraindicate specific procedures in the project.
* Other conditions deemed to prevent the subject from completing the examination program.
* Does not want to participate.
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Ministry of Science, Technology and Innovation, Denmark

OTHER_GOV

Sponsor Role collaborator

Vejle Hospital

OTHER

Sponsor Role collaborator

Danish National Research Foundation

OTHER

Sponsor Role collaborator

Aarhus University Hospital

OTHER

Sponsor Role collaborator

Augustinus Fonden

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Poul Videbech, Professor, M.D., Dr.Med.

Role: STUDY_DIRECTOR

Center of Psychiatric Research, Aarhus University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center of Psychiatric Research, Aarhus University Hospital

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CPF-TAD-1

Identifier Type: -

Identifier Source: org_study_id